Biotech Values

[corpstrat]

<<Mark-to-market is the biggest accounting controversy since the expensing of employee stock options >>

Yes, and it will be decided in the same corrupt, crony-capitalist way by bought congressmen and Treasury officials. I'd like to hear what Volcker recommends, since he presumably does not have a vested interest (unlike Buffett, for example).
Krugman, Roubini and Simon Johnson would also have intelligent and informed opinions unswayed by short-term WS interests.